Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter<sup>®</sup> system: a retrospective study.

Jin, Lidan; Fan, Wan-Hung; Luan, Yi; Wu, Meiqiong; Zhao, Wenhe

Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter^® system: a retrospective study.

Jin, Lidan; Fan, Wan-Hung; Luan, Yi; Wu, Meiqiong; Zhao, Wenhe.

Afiliación

Jin L; Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University College of Medicine, Hangzhou, China.
Fan WH; Hangzhou Watson Biotech, Hangzhou, China.
Luan Y; Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Wu M; Hangzhou Watson Biotech, Hangzhou, China.
Zhao W; Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University College of Medicine, Hangzhou, China.

PeerJ ; 9: e11366, 2021.

Article en En | MEDLINE | ID: mdl-33987029

Palabras clave

Breast cancer; Circulating tumor cells; CytoSorter; Early recurrence

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: PeerJ Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google